Completed
Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
NCT00503490
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
- Locations
-
- La Jolla, California, United States
- Los Angeles, California, United States
- Palo Alto, California, United States
- Orlando, Florida, United States